Study Title and Description
Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids.|
|Author||Glotz D., Charpentier B., Abramovicz D., Lang P., Rostaing L., Rifle G., Vanrenterghem Y., Berthoux F., Bourbigot B., Delahousse M., Chalopin JM., Cassuto E., Lefrançois N.|
|Country||Department of Nephrology, Saint-Louis Hospital, Paris, France. email@example.com|
Pubmed ID: 20386144
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.